Health Care › Biological Products (No Diagnostic Substances)

Titan Pharmaceuticals (TTNP) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with TTNP stock chart to see long term trends.

TTNP stock compared to

TTNP Income Statement

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Net Income:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

TTNP Cash Flow

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

TTNP Balance Sheet

Cash and Cash Equivalents:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Sabby Management, LLC

4,856,723 sh

4,856,723 sh
NEW

$803

Vanguard Group Inc

1,150,903 sh

$190

Northern Trust Corp

192,724 sh

$32

Bank Of America Corp /De/

6,125 sh

Blackrock Inc.

1,839 sh

Morgan Stanley

419 sh

Royal Bank Of Canada

5 sh

Virtu Financial LLC

0 sh

-142,611 sh
-100%

-$44

Tru Independence LLC

0 sh

-15,625 sh
-100%

-$4

Proequities, Inc.

0 sh

Data imported from Titan Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.